Adrenomedullin and Outcome in Severe Sepsis and Septic Shock

Mise à jour : Il y a 4 ans
Référence : NCT02393781

Femme et Homme

Extrait

The aim of this prospective study is to assess the prognostic value of bioactive plasma adrenomedullin (ADM) in 600 patients with severe sepsis or septic shock in an international multicenter study and to validate the findings concerning the association of ADM concentration and the use of vasopressor therapy, organ failure and outcome.


Critère d'inclusion

  • Severe sepsis ,Septic shock


Liens